Seungjoon Oh

1.7k total citations
67 papers, 1.3k citations indexed

About

Seungjoon Oh is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Seungjoon Oh has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Surgery and 23 papers in Molecular Biology. Recurrent topics in Seungjoon Oh's work include Diabetes Treatment and Management (15 papers), Pancreatic function and diabetes (14 papers) and Metabolism, Diabetes, and Cancer (13 papers). Seungjoon Oh is often cited by papers focused on Diabetes Treatment and Management (15 papers), Pancreatic function and diabetes (14 papers) and Metabolism, Diabetes, and Cancer (13 papers). Seungjoon Oh collaborates with scholars based in South Korea, United States and Czechia. Seungjoon Oh's co-authors include Suk Chon, Jeong‐Taek Woo, Young Seol Kim, Sang Youl Rhee, Sung Woon Kim, Jin‐Woo Kim, Kwang Sik Suh, Sung Wan Kim, Sang Ouk Chin and Sungwoon Kim and has published in prestigious journals such as PLoS ONE, Free Radical Biology and Medicine and Journal of Controlled Release.

In The Last Decade

Seungjoon Oh

62 papers receiving 1.3k citations

Peers

Seungjoon Oh

EDM

SURGE

PHYSI

GENET

Tiziana Filardi Italy

Yizhong Yan China

Katarı́na Rašlová Slovakia

Adrián M. Ramos Spain

Luis A. Quiñones Chile

Young Youl Hyun South Korea

Shuxia Guo China

Sadhbh O’Neill Ireland

Fuyuhiko Nishijima Japan

Cristino Cruz Mexico

Tiziana Filardi Italy

Seungjoon Oh

261 ×0.6

EDM

316 ×0.9

232 ×0.9

SURGE

208 ×0.8

PHYSI

74 ×0.5

GENET

Citations per year, relative to Seungjoon Oh Seungjoon Oh (= 1×) peers Tiziana Filardi

Countries citing papers authored by Seungjoon Oh

Since Specialization

Citations

This map shows the geographic impact of Seungjoon Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seungjoon Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seungjoon Oh more than expected).

Fields of papers citing papers by Seungjoon Oh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seungjoon Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seungjoon Oh. The network helps show where Seungjoon Oh may publish in the future.

Co-authorship network of co-authors of Seungjoon Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Seungjoon Oh. A scholar is included among the top collaborators of Seungjoon Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seungjoon Oh. Seungjoon Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsu, Po‐Hsuan, et al.. (2025). Information Disclosure and Peer Innovation: Evidence from Mandatory Reporting of Clinical Trials. Journal of Financial and Quantitative Analysis. 60(7). 3267–3310.

Hong, Eun‐Gyoung, Kyung Wan Min, Choon Hee Chung, et al.. (2025). Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52‐week, multicentre, randomized, placebo‐controlled, phase III clinical trial. Diabetes Obesity and Metabolism. 27(10). 5727–5736. 1 indexed citations

Nam, Ga Eun, Youn Huh, Wonsock Kim, et al.. (2025). Effects of Physical Activity on Medical Expenses among Individuals with Obesity in Korea: Insights from a Nationwide Study. Journal of Obesity & Metabolic Syndrome. 34(4). 424–433.

Kwak, Soo Heon, Kyung Ah Han, Eun Sook Kim, et al.. (2024). Long‐term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52‐week extension of a Phase 3 randomized controlled trial. Diabetes Obesity and Metabolism. 26(10). 4203–4212. 1 indexed citations

Yang, Ye, Kyung Wan Min, Kyung‐Soo Kim, et al.. (2023). Efficacy and safety of monotherapy with enavogliflozin in Korean patients with type 2 diabetes mellitus: Results of a 12‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase 2 trial. Diabetes Obesity and Metabolism. 25(8). 2096–2104. 11 indexed citations

Kwak, Soo Heon, Kyung Ah Han, Kyung‐Soo Kim, et al.. (2023). Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase III trial. Diabetes Obesity and Metabolism. 25(7). 1865–1873. 17 indexed citations

Park, So Young, Eun Mi Choi, Kwang Sik Suh, et al.. (2019). Tetrabromobisphenol A Promotes the Osteoclastogenesis of RAW264.7 Cells Induced by Receptor Activator of NF-kappa B Ligand In Vitro. Journal of Korean Medical Science. 34(41). e267–e267. 8 indexed citations

Suh, Kwang Sik, Eun Mi Choi, Yu‐Jin Kim, et al.. (2017). Perfluorooctanoic acid induces oxidative damage and mitochondrial dysfunction in pancreatic β-cells. Molecular Medicine Reports. 15(6). 3871–3878. 55 indexed citations

Chin, Sang Ouk, Sang Youl Rhee, Suk Chon, et al.. (2013). Investigation of Responsiveness to Thyrotropin-Releasing Hormone in Growth Hormone-Producing Pituitary Adenomas. International Journal of Endocrinology. 2013. 1–7. 2 indexed citations

10.

Chin, Sang Ouk, Jin Kyung Hwang, Sang Youl Rhee, et al.. (2013). Risk Factors for the Progression of Intima-Media Thickness of Carotid Arteries: A 2-Year Follow-Up Study in Patients with Newly Diagnosed Type 2 Diabetes. Diabetes & Metabolism Journal. 37(5). 365–365. 7 indexed citations

11.

Chin, Sang Ouk, Suk Chon, You‐Cheol Hwang, et al.. (2013). Change in Somatostatinergic Tone of Acromegalic Patients according to the Size of Growth Hormone-Producing Pituitary Tumors. Journal of Korean Medical Science. 28(12). 1774–1774. 1 indexed citations

12.

Chon, Suk, Yun Jung Lee, Gemma Fraterrigo, et al.. (2013). Evaluation of Glycemic Variability in Well-Controlled Type 2 Diabetes Mellitus. Diabetes Technology & Therapeutics. 15(6). 455–460. 39 indexed citations

13.

Chon, Suk, Yun Jung Lee, You‐Cheol Hwang, et al.. (2011). Autoimmune Hypoglycemia in a Patient with Characterization of Insulin Receptor Autoantibodies. Diabetes & Metabolism Journal. 35(1). 80–80. 21 indexed citations

14.

Rhee, Sang Youl, Young Seol Kim, Suk Chon, et al.. (2010). Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 91(1). e11–e14. 4 indexed citations

15.

Suh, Kwang Sik, Suk Chon, Seungjoon Oh, et al.. (2009). Prooxidative effects of green tea polyphenol (−)-epigallocatethin-3-gallate on the HIT-T15 pancreatic beta cell line. Cell Biology and Toxicology. 26(3). 189–199. 61 indexed citations

16.

Rhee, Sang Youl, Suk Chon, In‐Kyung Jeong, et al.. (2007). A Case of Type I Osteogenesis Imperfecta Differentially Diagnosed as a Cause of a Spinal Compression Fracture. Journal of Korean Endocrine Society. 22(6). 446–446.

17.

Rhee, Sang Youl, Suk Chon, In‐Kyung Jeong, et al.. (2007). Differences in Insulin Sensitivity and Secretory Capacity Based on OGTT in Subjects with Impaired Glucose Regulation. The Korean Journal of Internal Medicine. 22(4). 270–270. 20 indexed citations

18.

Choi, Suna, Seungjoon Oh, Minhyung Lee, & Sung Wan Kim. (2005). Glucagon-like Peptide-1 Plasmid Construction and Delivery for the Treatment of Type 2 Diabetes. Molecular Therapy. 12(5). 885–891. 26 indexed citations

19.

Lee, Minhyung, Malavosklish Bikram, Seungjoon Oh, David A. Bull, & Sung Wan Kim. (2004). Sp1-Dependent Regulation of the RTP801 Promoter and Its Application to Hypoxia-Inducible VEGF Plasmid for Ischemic Disease. Pharmaceutical Research. 21(5). 736–741. 54 indexed citations

20.

Ahn, Chul Woo, et al.. (2001). Decrease in carotid intima media thickness after 1 year of cilostazol treatment in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 52(1). 45–53. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact